Women’s Health Research
Juneau Biosciences is dedicated to genetic discoveries that will revolutionize the approach to women’s health care. Our research is currently focused on developing diagnostic tools and therapies for endometriosis.
Chances are, you or someone you know suffers from endometriosis. The condition affects 176 million women worldwide.1 Every woman with endometriosis is affected in a different way; some experience pain, others infertility, others problems with their periods, and some have no symptoms at all. Endometriosis occurs when the tissue that normally lines the inside of the uterus (womb) appears in other parts of the body, most commonly in the pelvis.
Currently, there is no cure for endometriosis. Its treatment is individualized, and the options include hormonal medication or targeted destruction of the abnormal tissue during surgery. The response to treatment is variable, and many women require multiple therapies and repeat treatments to control their symptoms. Presently, the only way to definitively diagnose endometriosis is by visually inspecting the womb and pelvic area for lesions and other abnormalities during surgery. Due to the difficulties, invasiveness, and expense of diagnosing the condition, the majority of women suffering from endometriosis do so for many years before receiving any treatment.
Juneau Biosciences is developing a non-invasive diagnostic test designed to identify the genes that contribute to the development of endometriosis. This test will allow for improved treatments of endometriosis.
For more details on our current endometriosis research, or to find out how you can participate in our study, please visit our End to Endo webpage.